Transdermal Rotigotine Patch Patent Is Invalid, Federal Circuit Affirms
WASHINGTON, D.C. — A circuit judge sitting by designation in the District of Delaware did not err in declaring various claims of a patent directed to transdermal rotigotine patches for the...To view the full article, register now.
Already a subscriber? Click here to view full article